Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant

scientific article

Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1378/CHEST.125.5.1952
P698PubMed publication ID15136414

P50authorCatherine M GreeneQ56915426
P2093author name stringNoel G McElvaney
Mark L Brantly
Clifford C Taggart
Matthew W Lawless
Shane J O'Neill
Alan T Mulgrew
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1952-1957
P577publication date2004-05-01
P1433published inChestQ5093377
P1476titleZ alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant
P478volume125

Reverse relations

cites work (P2860)
Q37144496A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema
Q38797163Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies
Q38092905Airway disease in alpha-1 antitrypsin deficiency
Q37056312Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
Q37986292Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent
Q35063726Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
Q36846798Alpha-1-antitrypsin deficiency: current concepts
Q38581002Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis
Q34428996Alpha1-antitrypsin deficiency
Q36925199Alpha1-antitrypsin deficiency: a clinical-genetic overview
Q38937853An ECLIPSE View of Alpha-1 Antitrypsin Deficiency
Q41112254Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema
Q90515735Clarifying the Risk of Lung Disease in SZ α1-antitrypsin Deficiency
Q57778139Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
Q36032652Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.
Q36444154Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy.
Q42176276Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Q24630805Genes and chronic obstructive pulmonary disease
Q57980231Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z α1-Antitrypsin
Q39085645Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin
Q33880491Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
Q42686567Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes
Q37804626Lung disease associated with alpha1-antitrypsin deficiency
Q37326944Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium
Q37466723New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy
Q35665638Novel aspects of pathogenesis and regeneration mechanisms in COPD
Q51536039Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema.
Q37395759Oxidative damage to nucleic acids in severe emphysema
Q37343918Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema
Q43180243Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease
Q37203729Polymers and inflammation: disease mechanisms of the serpinopathies
Q35755014Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo
Q35098361Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.
Q37447482Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery
Q34928474Protein misfolding and the serpinopathies
Q42790541Proteostasis: a new therapeutic paradigm for pulmonary disease
Q23911017Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis. Alpha-1 protocol
Q38111790Recent advances in α-1-antitrypsin deficiency-related lung disease
Q28387428SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort
Q37303247Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
Q39899143Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization
Q55259593The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.
Q38604663The Natural History of Lung Function in Severe Deficiency of Alpha-1 Antitrypsin Following Orthotopic Liver Transplantation: A Case Report
Q51465407The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
Q55011363The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.
Q35162540The prevalence of alpha-1 antitrypsin deficiency in Ireland
Q37894093The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency
Q36378692The selective advantage of alpha1-antitrypsin deficiency
Q38092851Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency
Q61044333Update on α-antitrypsin deficiency
Q35233352Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
Q33901639Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease
Q35607245alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis
Q37474870alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies
Q37855954α(1)-antitrypsin deficiency and inflammation

Search more.